Effect of IVIG Formulation on IgG Binding to Self- and Exo- Antigens In Vitro and In Vivo.
In relation to the recent trials of Intravenous Immunoglobulin (IVIG) in Alzheimer's Disease (AD) it was demonstrated that different IgG preparations contain varying amounts of natural anti-amyloid β (Aβ) antibodies as measured by ELISA. We therefore investigated the relevance of ELISA data for...
Main Authors: | Susann Cattepoel, Annette Gaida, Alain Kropf, Marc W Nolte, Reinhard Bolli, Sylvia M Miescher |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4999199?pdf=render |
Similar Items
-
IgG Glyco-Engineering to Improve IVIg Potency
by: Christine W. Bruggeman, et al.
Published: (2018-10-01) -
Intravenous immunglobulin binds beta amyloid and modifies its aggregation, neurotoxicity and microglial phagocytosis in vitro.
by: Susann Cattepoel, et al.
Published: (2013-01-01) -
Impact of Antigen Density on the Binding Mechanism of IgG Antibodies
by: Maya Hadzhieva, et al.
Published: (2017-06-01) -
Dimeric IgG complexes from IVIg are incapable of inducing in vitro neutrophil degranulation or complement activation.
by: Iwan Kustiawan, et al.
Published: (2018-01-01) -
Responses of IgE, IgG1, and IgG4 to concanavalin A-binding Blomia tropicalis antigens in allergic patients
by: K.C. Almeida, et al.
Published: (2006-11-01)